Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Port-Wine Stain 1Neurofibromatosis 1 1Neurofibromatoses 1Hemangioma, Capillary 1

Interventions

Specimen Handling 288Magnetic Resonance Spectroscopy 238pembrolizumab 228Carboplatin 187Cisplatin 153Biopsy 151Cyclophosphamide 144Paclitaxel 133Nivolumab 123Gemcitabine 113Bevacizumab 106Radiotherapy 96Dexamethasone 86Pemetrexed 83fludarabine 78Fluorouracil 76Doxorubicin 76Docetaxel 76atezolizumab 73Radiation 72Leucovorin 70Rituximab 68Oxaliplatin 66venetoclax 61durvalumab 61Prednisone 61Vincristine 56Cetuximab 56Lenalidomide 55Etoposide 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lasers × 30 days × Clear all
NCT07183644 2026-06-05

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

NCT06934928 2026-06-04

Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase NA Suspended
10 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡